文献速递血管炎

ANCA相关性血管炎患者血流感染风险高、病原体多样且与血液透析和血浆置换相关

High risk of bloodstream infections, diverse causal pathogens and association with haemodialysis and plasma exchange in ANCA-associated vasculitis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

基于丹麦全国登记数据,937例2010至2018年新诊断ANCA相关性血管炎患者与3476名年龄性别匹配对照比较,患者血流感染发生率显著更高(34.5/1000人年 vs 4.8/1000人年),接受血液透析或血浆置换者风险更高。

要点

  • ANCA相关性血管炎患者血流感染发生率34.5/1000人年,显著高于对照的4.8/1000人年。
  • 血液透析者HR 34.8、血浆置换者HR 14.6,面临更高感染率。
  • 首次血流感染后一年死亡率患者36.3%与对照34.5%同样高。

核心结论

  • ANCA相关性血管炎患者面临高血流感染风险、微生物多样性增加和一年死亡率增高,中心静脉导管相关干预是唯一风险因素。

研究设计与样本

  • 使用丹麦全国登记数据,纳入2010至2018年诊断的937例新发ANCA相关性血管炎患者,随访至首次血流感染、死亡或最长5年。
  • 对照按年龄和性别1:4匹配,共3476名对照。

主要发现

  • 937例患者中80例(8.5%)共发生111次血流感染,3476名对照中58例(1.7%)共发生65次血流感染。
  • 血流感染发生率为34.5/1000人年 vs 4.8/1000人年。
  • 首次血流感染一年HR为10.5(95%CI 5.58-11.9),接受血液透析者HR 34.8(95%CI 3.35-360.8),接受血浆置换者HR 14.6(95%CI 3.79-56.6)。
  • 首次血流感染后一年死亡率患者36.3%、对照34.5%。
  • 最常见微生物为大肠埃希菌、金黄色葡萄球菌、肠球菌和链球菌,两组相似;患者微生物多样性更高,48.6%归因于凝固酶阴性葡萄球菌、肺炎克雷伯菌、铜绿假单胞菌和真菌等其他病原体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Infections from immunosuppressive treatment are a major cause of hospitalization and mortality in ANCA-associated vasculitis (AAV). This study examines bloodstream infections (BSIs) in incident AAV patients, comparing incidence, bacterial distribution and risk to the general population, with emphasis on central venous catheters (CVCs). METHODS: Using Danish nationwide registries, we studied patients diagnosed from 2010 to 2018, followed until first BSI, death or a maximum of 5 years. Controls were matched 1:4 by age and sex. Cumulative incidence was estimated using Aalen-Johansen, and adjusted Cox regression modelled survival time. RESULTS: A total of 111 BSIs were identified in 80 (8.5%) of 937 AAV patients, compared with 65 BSIs in 58 (1.7%) of 3476 controls. The incidence of BSIs was significantly higher in AAV patients (34.5/1000 person-years against 4.8/1000 person-years). One-year hazard ratio (HR) for first-time BSIs was significantly elevated in AAV patients (HR 10.5, [95% CI 5.58-11.9]), and those receiving haemodialysis (HR 34.8, 95% CI 3.35-360.8) or plasma exchange (HR 14.6, 95% CI 3.79-56.6) faced even higher infection rates. Following first-time BSI, one-year mortality rates were equally high in AAV patients (36.3%) and controls (34.5%). Most common microbial agents-Escherichia coli, Staphylococcus aureus, enterococci and streptococci-were similar between the two groups. However, AAV patients exhibited higher microbial diversity, with 48.6% attributed to other pathogens like coagulase-negative staphylococci, Klebsiella pneumoniae, Pseudomonas aeruginosa and fungi. CONCLUSION: AAV patients face high BSI risk, diverse microbiology and increased one-year mortality, with CVC-related interventions as solitary risk factors.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Bruun NT, Kofod DH, Carlson N, et al. High risk of bloodstream infections, diverse causal pathogens and association with haemodialysis and plasma exchange in ANCA-associated vasculitis. Rheumatology (Oxford). 2025. PMID: 40828891. doi:10.1093/rheumatology/keaf438

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。